ProAssurance Q3 net income $1.4M; merger with Doctors Co. pending regulatory approvals

PROASSURANCE CORP

2025-Q3 EPS reported $0.34 revenue$828,385,000

Q3 net income $1.4M ($0.03 diluted EPS); operating income $7.9M ($0.15 diluted EPS).
Consolidated net premiums written $261.3M; Specialty P&C renewal premiums up 8%.
Non-GAAP combined ratio 112.2% (consolidated), 109.1% (Specialty P&C).
Book value per share $25.37, up from $23.49 at year-end 2024.
Doctors Co. merger approved by 5 state regulators; pending in CA, PA, TX; closing expected by June 30, 2026.

item 2.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.